Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2009, Article ID 679830, 7 pages
http://dx.doi.org/10.1155/2009/679830
Research Article

Prognostic Value of Microvascular Density in Dukes A and B (T1–T4, N0, M0) Colorectal Carcinomas

1Digestive Service, Hospital Universitario Miguel Servet, 50009, Zaragoza, Spain
2Department of Pathology, Hospital Clínico Universitario Lozano Blesa, 50009, Zaragoza, Spain
3Department of Emergency, Hospital Universitario Miguel Servet, 50009, Zaragoza, Spain

Received 9 March 2009; Accepted 23 August 2009

Academic Editor: Andrew Thillainayagam

Copyright © 2009 Rafael Uribarrena A et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Fielding, “Staging systems,” in Cancer of the Colon, Rectum, and Anus, A. Cohen and S. Vimawer, Eds., p. 207, McGraw-Hill, New York, NY, USA, 1995. View at Google Scholar
  2. S. H. Itzkowitz, “Cancer gastrointestinal: cancer de colon y recto,” in Digestive Diseases Self Education Program, C. M. Wilcox, Ed., p. 25, Medical Trends, Barcelona, Spain, 2001. View at Google Scholar
  3. P. Hermanek, “pTNM and residual tumor classifications: problems of assesment and prognostic significance,” The World Journal of Surgery, vol. 19, pp. 180–190, 1995. View at Google Scholar
  4. A. J. Bilchik, S. Saha, D. Wiese et al., “Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial,” Journal of Clinical Oncology, vol. 19, no. 4, pp. 1128–1136, 2001. View at Google Scholar · View at Scopus
  5. J. Ovaska, H. Järvinen, H. Kujari et al., “Follow-up of patients operated on for colorectal carcinoma,” American Journal of Surgery, vol. 159, no. 6, pp. 593–596, 1990. View at Google Scholar · View at Scopus
  6. R. C. Newland, P. H. Chapuis, M. T. Pheils, and J. G. MacPherson, “The relationship of survival to staging and grading of colorectal carcinoma: a prospective study of 503 cases,” Cancer, vol. 47, no. 6, pp. 1424–1429, 1981. View at Google Scholar · View at Scopus
  7. L. M. Ellis and I. J. Fidler, “Angiogenesis and metastasis,” The European Journal of Cancer, vol. 32A, no. 14, pp. 2451–2460, 1996. View at Google Scholar
  8. N. Ferrara and T. Davis-Smyth, “The biology of vascular endothelial growth factor,” Endocrine Reviews, vol. 18, no. 1, pp. 4–25, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. I. J. Fidler and L. M. Ellis, “The implications of angiogenesis for the biology and therapy of cancer metastasis,” Cell, vol. 79, no. 2, pp. 185–188, 1994. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Folkman, “Angiogenesis in cancer, vascular, rheumatoid and other disease,” Nature Medicine, vol. 1, no. 1, pp. 27–31, 1995. View at Google Scholar · View at Scopus
  11. S. A. Stacker, C. Caesar, M. E. Baldwin et al., “VEGF-D promotes the metastatic spread of tumor cells via the lymphatics,” Nature Medicine, vol. 7, no. 2, pp. 186–191, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Weidner, “Tumor angiogenesis: review of current applications in tumor prognostication,” Seminars in Diagnostic Pathology, vol. 10, no. 4, pp. 302–313, 1993. View at Google Scholar · View at Scopus
  13. C. H. Blood and B. R. Zetter, “Tumor interactions with the vasculature: angiogenesis and tumor metastasis,” Biochimica et Biophysica Acta, vol. 1032, no. 1, pp. 89–118, 1990. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Weidner, “Intratumoral vascularity as a prognostic factor in cancers of the urogenital tract,” The European Journal of Cancer A, vol. 32, no. 14, pp. 2506–2512, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Weidner, P. R. Carroll, J. Flax, W. Blumenfeld, and J. Folkman, “Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma,” American Journal of Pathology, vol. 143, no. 2, pp. 401–409, 1993. View at Google Scholar · View at Scopus
  16. R. E. Frank, T. J. Saclarides, S. Leurgans, N. J. Speziale, E. A. Drab, and D. B. Rubin, “Tumor angiogenesis as a predictor of recurrence and survival in patients with node-negative colon cancer,” Annals of Surgery, vol. 222, no. 6, pp. 695–699, 1995. View at Google Scholar · View at Scopus
  17. Y. Takebayashi, S. I. Akiyama, K. Yamada, S. Akiba, and T. Aikou, “Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma,” Cancer, vol. 78, no. 2, pp. 226–231, 1996. View at Google Scholar · View at Scopus
  18. C. J. Engel, S. T. Bennett, A. F. Chambers, G. S. Doig, N. Kerkvliet, and P. O. O'Malley, “Tumor angiogenesis predicts recurrence in invasive colorectal cancer when controlled for Dukes sataging,” The American Journal of Surgical Pathology, vol. 20, no. 10, pp. 1260–1265, 1996. View at Google Scholar
  19. T. J. Saclarides, N. J. Speziale, E. Drab, D. Szeluga, and D. B. Rubin, “Tumor angiogenesis and rectal carcinoma,” Diseases of the Colon and Rectum, vol. 37, no. 9, pp. 921–926, 1994. View at Google Scholar · View at Scopus
  20. N. Weidner, J. P. Semple, W. R. Welch, and J. Folkman, “Tumor angiogenesis and metastasis. Correlation in invasive breast carcinoma,” The New England Journal of Medicine, vol. 324, no. 1, pp. 1–8, 1991. View at Google Scholar · View at Scopus
  21. Y. Takahashi, S. L. Tucker, Y. Kitadai et al., “Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer,” Archives of Surgery, vol. 132, no. 5, pp. 541–546, 1997. View at Google Scholar · View at Scopus
  22. S. M. Kang, K. Maeda, N. Onoda et al., “Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis,” International Journal of Cancer, vol. 74, no. 5, pp. 502–507, 1997. View at Google Scholar · View at Scopus
  23. Y. Takahashi, C. D. Bucana, K. R. Cleary, and L. M. Ellis, “P53, vessel count, and vascular endothelial growth factor expression in human colon cancer,” International Journal of Cancer, vol. 79, no. 1, pp. 34–38, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Giatromanolaki, G. P. Stathopoulos, E. Tsiobanou et al., “Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma,” Cancer, vol. 86, no. 8, pp. 1421–1430, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Onogawa, Y. Kitadai, S. Tanaka, T. Kuwai, S. Kimura, and K. Chayama, “Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma,” Cancer Science, vol. 95, no. 1, pp. 32–39, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Zheng, M.-Y. Han, Z.-X. Xiao, J.-P. Peng, and Q. Dong, “Clinical significance of vascular endothelial growth factor expression and neovascularization in colorectal carcinoma,” World Journal of Gastroenterology, vol. 9, no. 6, pp. 1227–1230, 2003. View at Google Scholar · View at Scopus
  27. C. A. Staton, A. S. Chetwood, I. C. Cameron, S. S. Cross, N. J. Brown, and N. W. Reed, “The angiogenic switch occurs at the adenoma stage of the adenoma-carcinoma sequence in colorectal cancer,” Gut, vol. 56, no. 10, pp. 1426–1432, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. I. D. Wang, P. Wu, J. D. Mao, H. Huang, and F. Zang, “Relationship between vascular invasion, vascular density and micrometastasis,” World Journal of Gastroenterology, vol. 13, no. 46, pp. 6269–6273, 2007. View at Google Scholar · View at Scopus
  29. P. M. Pavlopoulos, A. E. Konstantinidou, E. Agapitos, N. Kavantzas, P. Nikolopoulou, and P. Davaris, “A morphometric study of neovascularization in colorectal carcinoma,” Cancer, vol. 83, no. 10, pp. 2067–2075, 1998. View at Google Scholar · View at Scopus
  30. F. Cianchi, A. Palomba, L. Messerini et al., “Tumor angiogenesis in lymph node-negative rectal cancer: correlation with clinicopathological parameters and prognosis,” Annals of Surgical Oncology, vol. 9, no. 1, pp. 20–26, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. C. I. Baeten, K. Castermans, H. F. Hillen, and A. W. Griffioen, “Proliferating endothelial cells and leukocyte infiltration as prognostic markers in colorectal cancer,” Clinical Gastroenterology and Hepatology, vol. 4, no. 11, pp. 1351–1357, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Lindmark, B. Gerdin, C. Sundberg, L. Pahlman, R. Bergstrom, and B. Glimelius, “Prognostic significance of the microvascular count in colorectal cancer,” Journal of Clinical Oncology, vol. 14, no. 2, pp. 461–466, 1996. View at Google Scholar · View at Scopus
  33. B. F. Banner, R. Whitehouse, S. P. Baker, and R. S. Swanson, “Tumor angiogenesis in stage II colorectal carcinoma: association with survival,” American Journal of Clinical Pathology, vol. 109, no. 6, pp. 733–737, 1998. View at Google Scholar · View at Scopus
  34. J. D. White, P. W. Hewett, D. Kosuge et al., “Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma,” Cancer Research, vol. 62, no. 6, pp. 1669–1675, 2002. View at Google Scholar · View at Scopus
  35. G. M. Boxer, E. Tsiompanou, T. Levine, R. Watson, and R. H. Begent, “Immunohistochemical expression of vascular endothelial growth factor and microvessel counting as prognostic indicators in node-negative colorectal cancer,” Tumor Biology, vol. 26, no. 1, pp. 1–8, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. C. C. Compton, L. P. Fielding, L. J. Burgart et al., “Prognostic factors in colorectal cancer: college of American Pathologists consensus statement 1999,” Archives of Pathology and Laboratory Medicine, vol. 124, no. 7, pp. 979–994, 2000. View at Google Scholar · View at Scopus
  37. M. Bouvet, M. Milas, G. G. Giacco et al., “Predictors of recurrence after local excision and postoperative chemoradiation therapy of adenocarcinoma of the rectum,” Annals of Surgical Oncology, vol. 6, no. 1, pp. 26–32, 1999. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Di Gregorio, P. Benatti, L. Losi et al., “Incidence and survival of patients with dukes A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study,” International Journal of Colorectal Disease, vol. 20, no. 2, pp. 147–154, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. G. J. Offerhaus, F. M. Giardiello, J. A. Bruijn, T. Stijnen, E. N. Molyvas, and G. J. Fleuren, “The value of immunohistochemistry for collagen IV expression in colorectal carcinomas,” Cancer, vol. 67, no. 1, pp. 99–105, 1991. View at Google Scholar · View at Scopus
  40. O. Celen, E. Yildirim, and U. Berberoglu, “Factors influencing outcome of surgery for stage I rectal cancer,” Neoplasma, vol. 51, no. 6, pp. 487–490, 2004. View at Google Scholar · View at Scopus
  41. C. Hassan, A. Zullo, M. Risio, F. P. Rossini, and S. Morini, “Histologic risk factors and clinical outcome in colorectal malignant polyp: a pooled-data analysis,” Diseases of the Colon and Rectum, vol. 48, no. 8, pp. 1588–1596, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. A. N. Meguerditchian, I. Bairati, R. Lagace, F. Harel, and A. Kibrite, “Prognostic significance of lymphovascular invasion in surgically cured rectal carcinoma,” American Journal of Surgery, vol. 189, no. 6, pp. 707–713, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. D. M. Goldenberg, R. M. Sharkey, and F. J. Primus, “Carcinoembryonic antigen in histopathology: immunoperoxidase staining of conventional tissue sections,” Journal of the National Cancer Institute, vol. 57, no. 1, pp. 11–22, 1976. View at Google Scholar · View at Scopus